ng-nitroarginine methyl ester has been researched along with ST Elevated Myocardial Infarction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Böhm, F; Collado, A; Jiao, T; Jurga, J; Mahdi, A; Pernow, J; Saleh, N; Tengbom, J; Verouhis, D; Yang, J; Zhou, Z | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and ST Elevated Myocardial Infarction
Article | Year |
---|---|
Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection through the purinergic P2Y
Topics: Adenosine Triphosphate; Animals; Cyclic GMP-Dependent Protein Kinases; Erythrocytes; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Soluble Guanylyl Cyclase; ST Elevation Myocardial Infarction | 2022 |